’Shrooms therapy leads the pack in psychedelic medicine, but rollout is bumpy

’Shrooms therapy leads the pack in psychedelic medicine, but rollout is bumpy

In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally occurring hallucinogen better known as magic mushrooms, or “shrooms,” has decisively pulled ahead of the pack.

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us - Psychedelic Alpha

Here at Psychedelic Alpha, we spend a great deal of time writing about the pursuit of regulatory approval for psychedelic medicines, with a key focus on the FDA pipeline, but we also cover other pathways to psychedelic access that don’t hinge on traditional marketing authorisation.While some of those pathways have emerged internationally—such as in Switzerland, Germany, and Australia—certain U.S. Source